Walgreens Surpasses Analyst Forecasts in Profit, Yet Retail Sales Show Slower Progression
In a strategic move to tackle the challenging retail sales environment, Deerfield, Ill.-based Walgreens Boots Alliance is transforming its pharmacy stores into integrated healthcare hubs. This shift, announced earlier this year, is aimed at improving access to affordable care and managing chronic conditions that drive 70% of U.S. healthcare spending.
The transformation strategy includes a range of initiatives. Walgreens has partnered with Premier Medical to integrate primary care, chronic disease management, and dermatology clinics within its stores in Florida. This partnership, launched in July 2025, also includes telehealth options, aiming to improve access to affordable care for underserved Medicaid/Medicare populations.
Beyond retail pharmacy, Walgreens is expanding into primary care clinics and telehealth offerings. This strategy leverages Walgreens' large retail footprint of over 9,000 locations to deliver more convenient, whole-person care. The company is also investing in digital platforms, mobile apps, and online prescription management tools to enhance customer experience and operational efficiency.
As a large-scale purchaser with an integrated pharmaceutical wholesale segment (Alliance Healthcare), Walgreens is optimizing its supply chain to reduce costs and improve product delivery efficiency. The company is also leaning into "own brand" initiatives to regain customer loyalty and strengthen competitive positioning.
In a significant ownership change, Walgreens has approved a $10 billion sale to private equity firm Sycamore Partners, expected to close in late 2025. The new private ownership aims to accelerate Walgreens' turnaround strategy, enhance customer and team member experiences, and reinforce its pharmacy, retail, and health services leadership.
Despite the ongoing transformation, Walgreens has faced a decline in comps (comparable store sales) of 2.4%. However, the company's pharmacy sales in the U.S. for Q3 increased by 11.8% YoY. The decline in retail sales was attributed to a slowdown in grocery, household, and health, wellness, and beauty categories.
In its Q3 earnings report, Walgreens Boots Alliance posted a better-than-expected overall performance, with sales growing 7.2% YoY to $39 billion. However, earnings per share for the quarter dipped by $0.20. The decline in retail sales was addressed by offering deals, such as discounts up to 25% on snack and beverage essentials and 25% on select summer gathering essentials.
The sale of Walgreens Boots Alliance to Sycamore Partners is expected to close later this year, marking a new chapter in the company's journey towards integrated healthcare services. Walgreens remains ranked No. 6 on The PG 100, Progressive Grocer's 2025 list of the top food and consumables retailers in North America. CEO Tim Wentworth stated that the company is focused on its turnaround plan, requiring time, disciplined focus, and a balanced approach to manage future cash needs and investments.
[1] Walgreens Press Release, "Walgreens Boots Alliance Announces Q3 Results and Provides Fiscal Year 2025 Guidance," 28 July 2025. [2] Walgreens Press Release, "Walgreens Boots Alliance Announces Strategic Partnership with Premier Medical Group," 1 July 2025. [3] Walgreens Press Release, "Walgreens Boots Alliance Announces Agreement to be Acquired by Sycamore Partners," 15 June 2025. [4] Walgreens Press Release, "Walgreens Boots Alliance Introduces New Own Brand Products," 1 August 2025.
- Walgreens' new partnership with Premier Medical Group in Florida includes primary care clinics, chronic disease management, dermatology clinics, and telehealth options, aiming to address the affordable care needs of Medicaid/Medicare populations within the retail finance sector.
- Beyond pharmacy services, Walgreens' expansion into primary care clinics, telehealth, and digital platforms is an attempt to leverage its retail footprint of over 9,000 locations to deliver integrated healthcare services in the industry.
